Edge Medical Repurchases 85,500 H-Shares, Treasury Stock Rises to 4.32 Million

Bulletin Express10-29

Shenzhen Edge Medical Co., Ltd. (Edge Medical-B) disclosed that it bought back 85,500 H-shares on 29 October 2026 via on-exchange transactions. The shares were repurchased at prices ranging from HKD 30.92 to HKD 32.00, for a total consideration of HKD 2.68 million.

Following the transaction, the company’s outstanding share count (excluding treasury shares) fell by 0.0264% to 323.44 million, while treasury shares increased to 4.32 million. The overall issued share capital remains unchanged at 327.76 million shares because the repurchased stock is being held in treasury rather than cancelled.

The buyback was executed under the mandate approved on 25 June 2026, which authorises repurchases of up to 32.61 million shares. To date, Edge Medical-B has repurchased 2.71 million shares under this mandate, equivalent to 0.83% of the issued share base at the mandate date. A 30-day moratorium on new share issues or treasury-share disposals runs until 28 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment